cbdMD, Inc. (YCBD)
YCBD Stock Price Chart
Explore cbdMD, Inc. interactive price chart. Choose custom timeframes to analyze YCBD price movements and trends.
YCBD Company Profile
Discover essential business fundamentals and corporate details for cbdMD, Inc. (YCBD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
17 Nov 2017
Employees
42.00
Website
https://www.cbdmd.comCEO
T. Ronan Kennedy
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
YCBD Financial Timeline
Browse a chronological timeline of cbdMD, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 11 Feb 2026
Earnings released on 14 Aug 2025
EPS came in at -$0.21 falling short of the estimated -$0.02 by -950.00%, while revenue for the quarter reached $4.61M , missing expectations by -2.02%.
Earnings released on 15 May 2025
EPS came in at -$1.90 falling short of the estimated -$1.60 by -18.75%, while revenue for the quarter reached $4.75M , missing expectations by -7.63%.
Stock split effective on 7 May 2025
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Feb 2025
EPS came in at -$1.76 falling short of the estimated -$0.37 by -375.68%, while revenue for the quarter reached $5.11M , missing expectations by -1.42%.
Earnings released on 27 Dec 2024
EPS came in at -$9.06 , while revenue for the quarter reached $4.56M .
Earnings released on 14 Aug 2024
EPS came in at -$1.20 falling short of the estimated -$0.62 by -93.55%, while revenue for the quarter reached $5.17M , beating expectations by +7.57%.
Earnings released on 15 May 2024
EPS came in at -$10.80 falling short of the estimated -$0.75 by -1.34K%, while revenue for the quarter reached $4.38M , missing expectations by -18.95%.
Earnings released on 13 Feb 2024
EPS came in at -$5.36 falling short of the estimated -$0.74 by -624.32%, while revenue for the quarter reached $5.38M , missing expectations by -7.32%.
Earnings released on 29 Jan 2024
EPS came in at -$0.67 surpassing the estimated -$0.74 by +9.46%, while revenue for the quarter reached $5.71M .
Earnings released on 10 Aug 2023
EPS came in at -$9.28 surpassing the estimated -$21.60 by +57.04%, while revenue for the quarter reached $6.12M , missing expectations by -55.66%.
Earnings released on 15 May 2023
EPS came in at -$13.92 surpassing the estimated -$28.80 by +51.67%, while revenue for the quarter reached $6.24M , missing expectations by -48.00%.
Stock split effective on 25 Apr 2023
Shares were split 1 : 45 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Feb 2023
EPS came in at -$28.83 falling short of the estimated -$15.75 by -83.05%, while revenue for the quarter reached $6.09M , missing expectations by -47.09%.
Earnings released on 15 Dec 2022
EPS came in at -$90.09 falling short of the estimated -$1.35 by -6.57K%, while revenue for the quarter reached $7.86M , missing expectations by -28.55%.
Earnings released on 11 Aug 2022
EPS came in at -$7.21 falling short of the estimated -$2.25 by -220.44%, while revenue for the quarter reached $8.59M , missing expectations by -18.16%.
Earnings released on 13 May 2022
EPS came in at -$36.04 falling short of the estimated -$4.05 by -789.88%, while revenue for the quarter reached $9.63M , missing expectations by -3.71%.
Earnings released on 10 Feb 2022
EPS came in at -$14.41 falling short of the estimated -$11.53 by -25.00%, while revenue for the quarter reached $9.32M , missing expectations by -29.65%.
Earnings released on 17 Dec 2021
EPS came in at -$14.41 , while revenue for the quarter reached $9.79M , missing expectations by -12.95%.
Earnings released on 12 Aug 2021
EPS came in at -$0.01 falling short of the estimated -$0.01 by -75.13%, while revenue for the quarter reached $10.56M , missing expectations by -19.39%.
Earnings released on 12 May 2021
EPS came in at -$86.49 falling short of the estimated -$10.81 by -700.00%, while revenue for the quarter reached $11.80M , missing expectations by -81.48%.
Earnings released on 9 Feb 2021
EPS came in at -$64.86 falling short of the estimated -$5.41 by -1.10K%, while revenue for the quarter reached $12.33M , beating expectations by 0.00%.
Earnings released on 22 Dec 2020
EPS came in at -$57.66 falling short of the estimated -$4.12 by -1.30K%, while revenue for the quarter reached $11.70M .
YCBD Stock Performance
Access detailed YCBD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.